J&J's Stelara succeeds in chronic bowel disease study

Tuesday, October 9, 2018 - 07:50 in Health & Medicine

Johnson & Johnson said on Tuesday its blockbuster drug Stelara was found to be effective in treating a chronic bowel disease in a late-stage trial.

Read the whole article on Reuters:Science

More from Reuters:Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net